Bronchoscopy Market Size & Growth Forecast 2027–2036, By Segments (Product Usage, Age Group, Product Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Bronchoscopy Market size was worth USD 3.72 Billion in 2026 and is poised to grow at 7.63% CAGR between 2027 and 2036, surpassing USD 7.76 Billion by 2036. The industry revenue for 2027 is assessed at USD 3.96 Billion.

• Base Year Value (2026): USD 3.72 Billion
• CAGR (2027-2036): 7.63%
• Forecast Year Value (2036): USD 7.76 Billion
• Historical Data Period: 2022-2026
• Largest Region: North America
• Forecast Period: 2027-2036

Bronchoscopy Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America led in 2025 due to advanced healthcare infrastructure, specialized pulmonary care, modern hospitals, and strong adoption of minimally invasive diagnostic technologies.
  • Asia Pacific is expanding fastest as healthcare access, respiratory disease awareness, healthcare spending, advanced hospitals, and minimally invasive procedures increase.

• Segment Momentum:

  • Single-use disposable bronchoscopes held a 59.68% market share in 2025 and remain the fastest-growing segment by reducing cross-contamination risks, simplifying workflows, and eliminating complex reprocessing and sterilization requirements.
  • The pediatric segment is expanding rapidly due to advances in pediatric bronchoscopy equipment, increasing awareness of early respiratory disease diagnosis, and rising demand for specialized care for respiratory conditions in children.

• Market Expansion Drivers:

  • Rising prevalence of chronic respiratory diseases increasing demand for diagnostic bronchoscopy procedures
  • Growing adoption of minimally invasive pulmonary diagnostics improving procedural efficiency and outcomes
  • Expanding geriatric population base driving higher incidence of respiratory intervention procedures

• Leading Market Participants:

  Top companies in the bronchoscopy market include Olympus Corporation (Japan), Boston Scientific Corporation (United States), Ambu A/S (Denmark), FUJIFILM Holdings Corporation (Japan), Hoya Corporation (Japan), Karl Storz SE & Co. KG (Germany), Medtronic plc (Ireland), Johnson & Johnson (United States), Teleflex Incorporated (United States), CONMED Corporation (United States)

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 3.72 Billion
  • 2027 Estimated Market Size: USD 3.96 Billion
  • Projected Market Size: USD 7.76 Billion by 2036
  • Growth Forecasts: 7.63% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Single Use/disposable (Product Usage) | Adult (Age Group) | Flexible Bronchoscopes (Product Type)
  • Emerging Opportunity Segment: Single Use/disposable (Product Usage) | Pediatric (Age Group) | Flexible Bronchoscopes (Product Type)

Market Growth Drivers and Industry Trends

Rising prevalence of chronic respiratory diseases increasing demand for diagnostic bronchoscopy procedures

Increasing cases of respiratory disorders are creating a stronger need for accurate visualization, diagnosis, and evaluation of airway conditions. The bronchoscopy market growth is driven by healthcare providers adopting diagnostic procedures that help identify infections, tumors, airway abnormalities, and other pulmonary complications at earlier stages. As respiratory disease management becomes more focused on timely intervention and precise assessment, hospitals and specialized respiratory centers are expanding access to bronchoscopy technologies that support comprehensive pulmonary diagnostics.

Growing adoption of minimally invasive pulmonary diagnostics improving procedural efficiency and outcomes

Advancements in minimally invasive approaches are encouraging physicians to replace more invasive diagnostic methods with procedures that offer improved patient comfort and faster recovery. Growing adoption of minimally invasive pulmonary diagnostics will propel the bronchoscopy market growth as healthcare facilities invest in advanced bronchoscopic systems that enhance visualization, sampling accuracy, and procedural control. These technologies support safer interventions while reducing procedure-related complications, making bronchoscopy increasingly valuable across diagnostic and therapeutic pulmonary applications.

Expanding geriatric population base driving higher incidence of respiratory intervention procedures

The increasing elderly population is contributing to a higher prevalence of age-related respiratory conditions that require continuous monitoring and clinical intervention. Expanding geriatric demographics will boost the bronchoscopy market demand as older patients experience greater susceptibility to chronic lung diseases, infections, and airway complications. Healthcare systems are strengthening respiratory care capabilities to address the growing requirement for diagnostic and interventional procedures among aging populations.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising prevalence of chronic respiratory diseases increasing demand for diagnostic bronchoscopy procedures	2%	High	North America, Europe	High	Near Term
Growing adoption of minimally invasive pulmonary diagnostics improving procedural efficiency and outcomes	1.8%	High	Asia Pacific	High	Near Term
Expanding geriatric population base driving higher incidence of respiratory intervention procedures	1.6%	Moderate	Europe, Japan	High	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held the largest position in the bronchoscopy market in 2026, supported by advanced healthcare infrastructure, widespread availability of specialized pulmonary care, and strong adoption of sophisticated diagnostic and therapeutic technologies. The region has a well-established network of hospitals and specialty centers capable of performing complex respiratory procedures, supporting consistent demand for bronchoscopy systems. Increasing awareness and diagnosis of respiratory disorders are further contributing to procedure volumes, while improvements in minimally invasive techniques are encouraging the use of bronchoscopy for both diagnosis and treatment. Continued investment in modern medical equipment and emphasis on early disease detection are reinforcing the region's market leadership.

Asia Pacific is poised for the fastest growth in the bronchoscopy market as healthcare infrastructure continues to expand and access to specialized respiratory care improves. Rising awareness of pulmonary diseases, increasing healthcare expenditure, and the development of advanced hospitals are creating favorable conditions for greater use of bronchoscopy procedures. The growing burden of respiratory disorders is also increasing demand for reliable diagnostic technologies, particularly in developing healthcare systems where access to specialized services is improving. In addition, adoption of minimally invasive approaches and investments in modern medical facilities are expected to support broader penetration of bronchoscopy technologies across the region.

No card data available for this language/report.

Segment Leadership and Growth Trends

 

Product Usage Segment Analysis: Single Use/disposable (Largest & Fastest-Growing Segment)

The bronchoscopy market was led by the single use/disposable segment, which accounted for a 59.68% share in 2026 and is also expected to be the fastest-growing category. Growing emphasis on infection prevention, elimination of cross-contamination risks, and reduced dependence on complex reprocessing procedures has accelerated the adoption of disposable bronchoscopes across healthcare settings. These devices also improve workflow efficiency by ensuring immediate availability for emergency procedures while lowering maintenance and sterilization requirements. Rising awareness of patient safety and hospital-acquired infection prevention continues to reinforce demand for single-use solutions.

Age Group Segment Analysis: Adult (Largest Segment) vs Pediatric (Fastest-Growing Segment)

The adult segment dominated the market with an 83.1% share in 2026 due to the higher prevalence of chronic respiratory disorders, lung infections, pulmonary cancers, and other conditions requiring bronchoscopic diagnosis and intervention among adults. The increasing number of minimally invasive pulmonary procedures and growing demand for advanced diagnostic techniques have further strengthened utilization within this age group.

The pediatric segment is anticipated to experience the fastest growth as improvements in pediatric bronchoscopy equipment and increasing awareness of early respiratory disease diagnosis expand clinical adoption. Rising incidence of congenital airway abnormalities, pediatric respiratory infections, and specialized respiratory care services is encouraging broader use of bronchoscopy in younger patient populations.

Product Type Segment Analysis: Flexible Bronchoscopes (Largest & Fastest-Growing Segment)

Holding the largest share of the bronchoscopy market at 60.53% in 2026, flexible bronchoscopes also represent the fastest-growing product type. Their superior maneuverability, enhanced patient comfort, and ability to access complex airway structures make them the preferred choice for both diagnostic and therapeutic procedures. Flexible bronchoscopes support a wide range of clinical applications, including tissue biopsy, foreign body removal, airway inspection, and minimally invasive interventions. Continuous technological advancements in imaging quality, device flexibility, and compatibility with disposable designs are expected to sustain strong growth for this segment.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Product Usage	Single Use/disposable, Reusable	Single Use/disposable	Single Use/disposable
Age Group	Adult, Pediatric	Adult	Pediatric
Product Type	Rigid Bronchoscopes, Flexible Bronchoscopes, Others	Flexible Bronchoscopes	Flexible Bronchoscopes

Competitive Landscape and Market Positioning

Major players in the bronchoscopy market:

1. Olympus Corporation (Japan)
2. Boston Scientific Corporation (United States)
3. Ambu A/S (Denmark)
4. FUJIFILM Holdings Corporation (Japan)
5. Hoya Corporation (Japan)
6. Karl Storz SE & Co. KG (Germany)
7. Medtronic plc (Ireland)
8. Johnson & Johnson (United States)
9. Teleflex Incorporated (United States)
10. CONMED Corporation (United States)

The bronchoscopy market is evolving around technological refinement and the demand for more precise, minimally invasive diagnostic and therapeutic procedures. Competitive positioning is increasingly influenced by advancements in imaging quality, navigation capabilities, procedural accuracy, and workflow efficiency, with manufacturers seeking to improve clinical confidence and expand the range of applications. As healthcare systems emphasize earlier diagnosis and improved patient outcomes, companies with strong innovation pipelines and solutions that simplify complex procedures are gaining importance in the market landscape.

Industry Development/News

Company Name	Date	Key Development
Noah Medical	Jun-26	Noah Medical appointed Dr. Krish Bhadra as Chief Pulmonary Advisor to lead its strategic respiratory technology initiatives. The organizational change strengthens the company's internal expertise and clinical development pipeline for robotic-assisted bronchoscopy solutions.
RMC Health System	Apr-26	RMC Health System launched its Ion Bronchoscopy program in Northeast Alabama, deploying robotic-assisted lung biopsy capabilities. The initiative expands geographic access to advanced minimally invasive diagnostic procedures, accelerating technology adoption in pulmonary care.
UnityPoint Health – St. Luke’s	Feb-26	UnityPoint Health – St. Luke’s acquired the Ion endoluminal system to scale its pulmonary diagnostic capabilities. The integration of this robotic-assisted bronchoscopy platform expands clinical service offerings for evaluating suspicious lung nodules.
Ellis Medicine	Dec-25	Ellis Medicine opened the $500,000 Nan and Hugh Murphy Interventional Procedures Suite, integrating advanced Cone Beam CT imaging with the Ion Robotic Bronchoscopy platform. The facility expansion enhances clinical operational footprint and capacity for minimally invasive lung biopsies.
Intuitive Surgical	Oct-25	Intuitive Surgical received FDA clearance for artificial intelligence and imaging updates to its Ion lung biopsy robot. These enhancements introduce advanced navigation capabilities, strengthening the platform's competitive positioning in robotic-assisted bronchoscopy procedures.
Apreo	Aug-25	Apreo secured $130 million in funding, with participation from Intuitive Surgical's venture arm, to support a pivotal clinical trial for its emphysema treatment device. This significant investment accelerates the commercialization and clinical validation of advanced respiratory intervention technologies.
Johnson & Johnson	Mar-25	Johnson & Johnson's Monarch bronchoscopy robot secured FDA clearance for Monarch Quest. The update enables direct integration with live CT scans via compatibility with GE HealthCare's 3D C-arm imaging system, driving technology integration and advanced navigation in lung procedures.
Olympus	May-24	Olympus launched the BF-H1100 diagnostic and BF-1TH1100 therapeutic bronchoscopes, which are fully compatible with its flagship EVIS X1 endoscopy system. The rollout expands the company's product portfolio with slim-diameter, high-definition visualization tools for distal airways.
Medtronic	May-24	Medtronic published preliminary data from its VERITAS clinical study evaluating the ILLUMISITE fluoroscopic navigation platform. The study validates the efficacy of its electromagnetic navigational bronchoscopy technology, supporting market commercialization efforts.